Cargando…
ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma
Hepatic angiosarcoma (HAS) is a rare and highly lethal malignancy with few effective systemic treatments. Relatively little is known about the genetic abnormalities that drive this disease. As a result, there has been minimal progress towards applying targeted therapies to the treatment of HAS. We d...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349438/ https://www.ncbi.nlm.nih.gov/pubmed/30719217 http://dx.doi.org/10.18632/oncotarget.26521 |